Biotecnología
Biotecnología
Charles River Launches pHelper Offering for AAV-based Gene Therapies
10/03/2023 -
Designed to secure supply and streamline adeno-associated virus (AAV)-based gene therapy programs from early discovery through commercial manufacturing.
Evonik Opens New Facility for Pharmaceutical Lipids in Germany
10/03/2023 -
The types of lipids that can be produced at the facility will serve a broad range of RNA and gene therapies.
OTP Town Hall: Gene Therapy Chemistry, Manufacturing, and Controls – April 2023 - 04/25/2023
08/03/2023 -
The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting its next virtual town hall on Tuesday, April 25, 2023.
Porton Advanced CDMO Collaborates with DanausGT
07/03/2023 -
To accelerate the development of cell and gene therapies.
Clean Cells Launches Biopharmaceutical Quality Control Facility
07/03/2023 -
The new building will enable the company to develop its activities in innovative sectors, including gene therapy.
Charles River, Purespring Therapeutics Collaborate on Gene Therapy Manufacturing
02/03/2023 -
Plasmid CDMO alliance supports first gene therapy platform targeting kidney diseases.
Moderna, Life Edit Partner on In Vivo Gene Therapies
02/03/2023 -
Collaboration combines Moderna's mRNA platform with Life Edit's gene editing technologies, including base editing capabilities.
AskBio Receives EC Orphan Drug Designation for AB-1003 LGMD Treatment
02/03/2023 -
The drug will evaluate the safety, tolerability and efficacy of a single IV infusion of gene therapy in adult subjects.
Report Reveals Cell & Gene Therapy CDMO Market to Reach $18.6B by 2032
02/03/2023 -
New partnerships with pharma, biopharma companies have enabled CDMOs to fuel the rapid growth of capabilities and capacities.
Methods and Approaches for Capturing Post-Approval Safety and Efficacy Data on Cell and Gene Therapy Products - 04/27/2023
02/03/2023 -
Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual public listening meeting to solicit input on methods and approaches (e.g., use...
Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss
02/02/2023 -
Novel AAV capsid Anc80 enables efficient gene transfer.
Catalent Bolsters Cell and Gene Services
30/01/2023 -
Launches new service for end-to-end supply chain case management of cell and gene therapies.
Syner-G BioPharma Acquires RMC Pharma Solutions
30/01/2023 -
Provides additional pharmaceutical science services, adding development experience in all biologic modalities including cell and gene therapy.
Forge Biologics Receives PRIME Designation from EMA for Novel Gene Therapy
30/01/2023 -
PRIME designation granted to drug candidates that may offer a major therapeutic advantage over existing treatments.
Forge Biologics Strengthens Genetic Medicine CDMO Capabilities
30/01/2023 -
New leadership team appointments strengthen manufacturing capabilities with a focus on gene therapy clinical and commercial cGMP manufacturing.
Cryoport Partners with Syneos Health to Advance Cell & Gene Therapies
19/01/2023 -
Will provide the industry with a fully integrated biopharmaceutical and supply chain solution.
Be The Match BioTherapies Expands CRO Services
19/01/2023 -
Expanded service offering specializes in the design, implementation and oversight of cellular therapy clinical trials.
Charles River Launches eXpDNA Plasmid Platform
16/01/2023 -
Reduces plasmid development and production timelines while streamlining the development journey for cell and gene therapy and vaccine developers.
Fujifilm Irvine Scientific Launches BalanCD HEK293 Viral Feed
11/01/2023 -
Is designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based vaccines.
Ginkgo Bioworks Expands R&D Facilities with Opening of Bioworks7
10/01/2023 -
Increases its capacity and capabilities to serve its partners in the spaces of cell & gene therapy, biomanufacturing and general mammalian programming.
CCRM Partners with Membio to Streamline Production of Viral Vectors for Cell and Gene Therapies
10/01/2023 -
Will explore combining Membio’s bioreactor system with CCRM’s virus producing cell line.
